Stay updated on scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Sign up to get notified when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.

Latest updates to the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page reflects an administrative refresh of the study listing: the record/revision version updated (v3.5.2 → v3.5.3) along with updated posted/last-update dates. It also shows the Barcelona location details adjusted at a more specific formatting level (e.g., how the address is displayed), without changing the overall study location being listed or its main protocol elements.SummaryDifference1%

- Check19 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0. This appears to be a minor version update with no user-facing content changes.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded the MeSH term 'Mucopolysaccharidosis, MPS-III-A' to the study record.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded a screening threshold: Cohorts 1-3 require anti-AAV9 antibody titers ≥ 1:100 (ELISA) to be considered positive. The previous screening criterion for Cohort 4 antibody positivity at screening has been removed.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.